Physician profile
Monica Everett
NPI 1700485745
$862.86
in general payments reported to CMS, 2019-2025
9 companies · $81.64 in 2025
The $81.64 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $227 · 2023: $105 · 2024: $298 · 2025: $81.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $362.35 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $266.37 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $80.56 | 2023-2024 | Airsupra, Farxiga |
| Genentech USA, INC. | $41.64 | 2021 | |
| Astellas Pharma US INC | $37.32 | 2024 | Veozah |
| Biohaven Pharmaceuticals, INC. | $20.41 | 2021 | |
| Glaxosmithkline, LLC. | $20.25 | 2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.44 | 2024 | Jardiance |
| Exact Sciences Corporation | $15.52 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.